Ritazral Hynidate 20mg Tablet ER
By Ritazral Hynidate
Rx
10 Tablet ER in a Strip

Composition
Methylphenidate(20mg)

Manufacturer - Taj Pharma India Ltd
first floor, 15-6-108 afzal gunj, hyderabad, telangana 500012

Expires on or after
July, 2026

liver
Consult with your doctor for proper guidance before using Ritazral Hynidate 20mg Tablet ER. There is limited information available on the use of this medication in patients with liver disease. It is important to seek advice from a healthcare professional to understand any potential risks or considerations specific to liver issues when taking this medication.

kidney
Limited information is available on using Ritazral Hynidate 20mg Tablet ER in patients with kidney disease. It is advised to consult your doctor before using this medication, especially if you have underlying kidney issues.

alcohol
When taking Ritazral Hynidate 20mg Tablet ER, be aware that alcohol can increase drowsiness.

driving
Caution - Driving Ritazral Hynidate 20mg Tablet ER may cause dizziness, focus issues, and blurred vision, impacting your driving ability.

pregnancy
Ritazral Hynidate 20mg Tablet ER may not be safe during pregnancy. Animal studies suggest possible harm to the developing baby. Your doctor will evaluate the benefits and risks before prescribing. Please consult your doctor for guidance.

breastfeeding
Ritazral Hynidate 20mg Tablet ER is likely unsafe during breastfeeding as it may pass into breastmilk and harm the baby.
| Habit Forming | Yes |
| Chemical Class | Aralkylamines Derivative |
| Therapeutic Class | NEURO CNS |
| Action Class | Sympthatomimmetics-ADHD |
₹202
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025
